Abstract:What's new? Cancer‐associated fibroblasts (CAFs) contribute to the progression of lung cancer. Four and a half LIM domain protein‐2 (FHL2) is a component of focal adhesion structures. Here, the authors show that FHL2 is highly expressed in myofibroblasts in lung cancer tissue, and that FHL2 expressed by CAFs promotes proliferation and migration. FHL2 expression in CAFs also promotes the migration and invasion of cancer cells and angiogenesis in vitro, and metastatic dissemination in vivo. The findings suggest that FHL2 expression by CAFs enhances the progression of lung adenocarcinoma by promoting angiogenesis and metastasis. Cancer‐associated fibroblasts (CAFs) contribute to the progression of lung cancer. Four and a half LIM domain protein‐2 (FHL2) is a component of focal adhesion structures. We analyzed the function of FHL2 expressed by CAFs in lung adenocarcinoma. Expression of FHL2 in fibroblast subtypes was investigated using database of single‐cell RNA‐sequencing of lung cancer tissue. The role of FHL2 in the proliferation and migration of CAFs was assessed. The effects of FHL2 knockout on the migration and invasion of human lung adenocarcinoma cells and tube formation of endothelial cells induced by CAF‐conditioned medium (CM) were evaluated. The effect of FHL2 knockout in CAFs on metastasis was determined using a murine orthotopic lung cancer model. The prognostic significance of stromal FHL2 was assessed by immunohistochemistry in human adenocarcinoma specimens. FHL2 is highly expressed in myofibroblasts in cancer tissue. TGF‐β1 upregulated FHL2 expression in CAFs and FHL2 knockdown attenuated CAF proliferation. FHL2 knockout reduced CAF induced migration of A110L and H23 human lung adenocarcinoma cell lines, and the induction of tube formation of endothelial cells. FHL2 knockout reduced CAF‐induced metastasis of lung adenocarcinomas in an orthotopic model in vivo. The concentration of Osteopontin (OPN) in CM from CAF was downregulated by FHL2 knockout. siRNA silencing and antibody blocking of OPN reduced the pro‐migratory effect of CM from CAF on lung cancer cells. In resected lung adenocarcinoma specimens, positive stromal FHL2 expression was significantly associated with higher microvascular density and worse prognosis. In conclusion, FHL2 expression by CAFs enhances the progression of lung adenocarcinoma by promoting angiogenesis and metastasis.

FHL2 activates β-catenin/Wnt signaling by complexing with APC and TRIM63 in lung adenocarcinoma

FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway

MTHFD2 Promotes Tumorigenesis and Metastasis in Lung Adenocarcinoma by Regulating AKT/GSK‐3β/β‐catenin Signalling

Four-and-a-half LIM Protein 2 Promotes Invasive Potential and Epithelial-Mesenchymal Transition in Colon Cancer.

Downregulation And Growth Inhibitory Role Of Fhl1 In Lung Cancer

FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway

FHL2 expression by cancer‐associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma

Four and a Half LIM Protein 2 (FHL2) Negatively Regulates the Transcription of E-cadherin Through Interaction with Snail1.

The Four and a Half LIM Domains 2 (FHL2) Regulates Ovarian Granulosa Cell Tumor Progression Via Controlling AKT1 Transcription

Src-mediated Phosphorylation Converts FHL1 from Tumor Suppressor to Tumor Promoter

Suppression of FHL2 Expression Induces Cell Differentiation and Inhibits Gastric and Colon Carcinogenesis

Four and a Half LIM Domains 2 Contributes to the Development of Human Tongue Squamous Cell Carcinoma

Comprehensive pan-cancer analysis identifies FHL2 associated with poor prognosis in lung adenocarcinoma

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.

Oncogene Functions of FHL2 Are Independent from NF-κBIα in Gastrointestinal Cancer

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β–like signaling pathway

FHL1 Inhibits the Growth of Tongue Squamous Cell Carcinoma Cells Via G1/S Cell Cycle Arrest.

YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway

FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors

Fucosyltransferase 2 Induced Epithelial-Mesenchymal Transition Via TGF-β/Smad Signaling Pathway in Lung Adenocarcinaoma.

FAPP2 Promotes Tumor Cell Growth in Human Colon Cancer Through Activation of Wnt Signaling